It is important to know that CBSA will require all importers (including non-resident importers) and their trade chain partners to register for a CARM account, to allow your broker to release your goods and make entry on your behalf. Failure to apply for a CARM account will prevent you from importing. What is the timeline?…
Read More »
As of January 12, 2022, the effective date for the interim final rule published October 21, 2021 is delayed to March 7, 2022. On October 21, 2021, the Bureau of Industry and Security (BIS) published an interim final rule that establishes new controls on certain cybersecurity items for National Security (NS) and Anti-terrorism (AT) reasons,…
Read More »
UPDATE:12/29/21— The changes to the U.S. Harmonized Tariff Schedule (HTS) will take effect 30 days from the notice's publish date in the Federal Register. The proclamation amends tariff schedule provisions on Section 301 tariffs and on various trade agreements to conform to the changes found in the HTS. It also removes—effective January 1—Ethiopia, Guinea and…
Read More »
On December 23, President Biden signed the Uyghur Forced Labor Act. Under the act, all goods with a connection to China’s Xinjiang province are presumed to be made by forced labor, effective June 21. U.S. Customs and Border Protection (CBP) will also be responsible to produce guidance for importers by the effective date. The guidance…
Read More »
The Census Bureau’s Economic Management Division (EMD) is seeking public comments on new export reporting requirements related to the country of origin. EMD is proposing to add a conditional data element—country of origin—when foreign origin is selected in the Foreign/Domestic Origin Indicator field in the Automated Export System (AES). In addition to the new export…
Read More »
Owners or operators of companies that produce and distribute medical devices intended for commercial distribution in the U.S., including products that are imported for export only, must register annually with the FDA. Foreign and domestic medical device facilities that do not renew their registrations with the FDA by December 31, 2021, could be restricted from…
Read More »
According to a recent message sent out by U.S. Customs and Border Protection (CBP), “CBP will deny requests filed under 19 U.S.C. § 1504(b)(2) for an extension of time for liquidation of entries based solely on the pending Court of International Trade (CIT) litigation challenging the lawfulness of the Section 301 duties on Chinese goods…
Read More »
When importing—or exporting—goods under a lease agreement, it is important to understand that the items are not considered sold and that transaction value will not apply. Instead, importers must use one of the other methods of valuation, applied in sequential order, as part of their Reasonable Care. U.S. Customs and Border Protection’s (CBP) Informed Compliance…
Read More »
The three judges at the U.S. Court of International Trade, who are presiding over the Section 301 litigation, have scheduled for an oral argument to be held in New York City, on February 1. They also plan to broadcast the proceedings using a dedicated YouTube channel, which has yet to be identified. This news demonstrations…
Read More »
The Office of the U.S. Trade Representative (USTR) has announced an extension of 81 Section 301 tariff exclusions—which include certain medical-care products needed to address the COVID-19 pandemic—until May 31, 2022. USTR has also stated that the notice, “extends the 99 exclusions scheduled to expire on November 14, 2021, through November 30, 2021. Those exclusions…
Read More »
© 2024 Mohawk Global OTI No. 003952NF Terms of Use Privacy Policy